e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Propanc Biopharma, Inc. - Common Stock
(OP:
PPCB
)
10.40
UNCHANGED
Last Price
Updated: 3:35 PM EDT, Aug 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Propanc Biopharma, Inc. - Common Stock
< Previous
1
2
3
Next >
Propanc Biopharma Receives Certificate of Grant for “Proenzyme Composition” Patent from US Patent & Trademark Office
September 17, 2025
Fourth US Granted Patent Captures Claims for Future Clinical Dose of PRP
From
Propanc Biopharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 02, 2025
Via
Benzinga
Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum
September 02, 2025
Ethereum to Enhance Multi-Faceted Corporate Strategy of Cryptocurrency Exposure, Pharmaceutical Drug Development & Asset Acquisition
From
Propanc Biopharma, Inc.
Via
GlobeNewswire
Why Propanc stock Is Tumbling In Premarket Today
August 19, 2025
Via
Stocktwits
BioMedNewsBreaks — Propanc Biopharma, Inc. (NASDAQ: PPCB) Closes $4 Million Public Offering
August 29, 2025
Via
Investor Brand Network
D. Boral Capital Acted as Lead Bookrunner to Propanc Biopharma, Inc. (Nasdaq:PPCB) in Connection with its $4,000,000 Uplisting
August 28, 2025
Via
ACCESS Newswire
Propanc Biopharma Provides Shareholder Update
August 25, 2025
From
Propanc Biopharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 20, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 20, 2025
Via
Benzinga
Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
August 20, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 19, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 19, 2025
Via
Benzinga
Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ
August 19, 2025
From
Propanc Biopharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 19, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 18, 2025
Via
Benzinga
What's Going On With Propanc Shares Monday?
August 18, 2025
Propanc Biopharma shares are trading higher Monday. The company recently priced a $4 million public offering and began trading on the Nasdaq Capital Market.
Via
Benzinga
Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August
August 18, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 18, 2025
Via
Benzinga
Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!
August 18, 2025
Via
AB Newswire
Topics
Artificial Intelligence
US Stocks Mixed; Riskified Shares Dip After Q2 Results
August 18, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 18, 2025
Via
Benzinga
Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
August 18, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 15, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 15, 2025
Via
Benzinga
Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering
August 14, 2025
Propanc common stock expected to begin trading on Nasdaq under the symbol PPCB
From
Propanc Biopharma, Inc.
Via
GlobeNewswire
Propanc Biopharma’s Peer Reviewed Articles for Proenzymes Cancer Treatment Generates “Unprecedented” Interest
August 21, 2024
From
Propanc Biopharma, Inc.
Via
Business Wire
Propanc Biopharma Receives Notice of Allowance for “Proenzyme Composition” Patent in North America
August 14, 2024
From
Propanc Biopharma, Inc.
Via
Business Wire
Propanc Biopharma’s CSO Predicts PRP Could Solve Problem That Impacts Response Rate of Immune Checkpoint Inhibitors Treating Solid Tumors
July 17, 2024
From
Propanc Biopharma, Inc.
Via
Business Wire
Propanc Biopharma Receives Certificate of Grant for “Proenzymes Composition” Patent from Japanese Patent Office
June 25, 2024
From
Propanc Biopharma, Inc.
Via
Business Wire
Propanc Biopharma Receives Certificate of Grant for “Composition of Proenzymes for Cancer Treatment” Patent from European Patent Office
April 16, 2024
From
Propanc Biopharma, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Facebook
Twitter
YouTube